1. Pharmaceuticals and Drug Development

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

Written by Posted on Less than 0 min read

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–Sep. 3, 2024– KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for sebetralstat…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Combined effects of plastic pollution and seawater flooding amplify threats to coastal plant species

Two of the planet’s more pressing environmental stressors have the potential to alter the growth and reproductive output of plants found right along the world’s coastlines, a new study suggests. The research, published in the journal Environmental Pollution, is one of the first to examine the combined effects of seawater flooding and microplastic pollution on […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Injury dressings in first-aid kits provide a new technique to reveal shark species after bite incidents

Scientists have revealed that injury dressings found in first-aid kits can reliably be used to identify shark species involved in bite incidents by deploying medical gauze to gather DNA samples from aquatic equipment, such as surfboards. The Flinders University research shows that this new collection method can improve how shark-related incidents are investigated and can […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Some benefits of exercise stem from the immune system

The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race. Now, a new Harvard Medical School study published Nov. 3 in Science Immunology may offer a molecular explanation behind this century-old […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

450-million-year-old organism finds new life in Softbotics

Researchers in the Department of Mechanical Engineering at Carnegie Mellon University, in collaboration with paleontologists from Spain and Poland, used fossil evidence to engineer a soft robotic replica of pleurocystitid, a marine organism that existed nearly 450 million years ago and is believed to be one of the first echinoderms capable of movement using a […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New ways to study spinal cord malformations in embryos

A group of scientists at UCL have successfully created mechanical force sensors directly in the developing brains and spinal cords of chicken embryos, which they hope will improve understanding and prevention of birth malformations such as spina bifida. The study, published in Nature Materials and in collaboration with the University of Padua and the Veneto […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New tool enables a more complete and rapid decoding of the language of algal gene expression

A new method that research teams can use to measure and compare different forms of proteins and protein complexes helped reveal a previously unseen molecular signature of how algal genomes are controlled during the cell cycle. The publication, “pyMS-Vis, an open-source Python application for visualizing and investigating deconvoluted to-down mass spectrometric experiments: A histone proteoform […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

‘Robin Hood’ approach for tracking biodiversity

Elise Zipkin and her team at Michigan State University have developed a sort of “Robin Hood” approach to better understand and protect the world’s biodiversity. They’re using information from well-quantified animals to reveal insights about less common, harder-to-observe species. That is, they’re taking insights from the data-rich and giving to the data-poor. Now, they’re sharing […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New mouse models offer valuable window into COVID-19 infection

Scientists at La Jolla Institute for Immunology (LJI) have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19. According to their new study in eBioMedicine, these mouse models are important for COVID-19 research because their cells were engineered to include two important human molecules that are […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Evolution of taste: Early sharks were able to perceive bitter substances

A research team from the University of Cologne, in collaboration with colleagues from the Leibniz Institute for Food Systems Biology in Freising, has discovered a receptor for bitter taste in twelve different cartilaginous fish (sharks and rays). The receptor belongs to the so-called taste receptors type 2 (T2R), which also make humans perceive bitter and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […]
Written by
Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
  1. Pharmaceuticals and Drug Development

Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer

By Elana Gotkine HealthDay Reporter WEDNESDAY, Oct. 18, 2023 — For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published in the Oct. 19 issue of the New England Journal of Medicine. Stephen J. Freedland, M.D., from the Cedars-Sinai Medical Center in Los […]
Written by
CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections
  1. Pharmaceuticals and Drug Development

CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter THURSDAY, June 6, 2024 — Among emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Carl T. […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas

OSAKA, Japan, October 18, 2023, and CAMBRIDGE, Massachusetts, October 17, 2023 — Takeda (TSE:4502/NYSE: TAK) today announced that the Phase 3 ADMIRE-CD II study, assessing the efficacy and safety of Alofisel® (darvadstrocel) for the treatment of complex Crohn’s Perianal Fistulas (CPF), did not meet its primary endpoint of combined remission at 24 weeks, based on […]
Written by
  1. Clinical

Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults

SHANGHAI, June 18, 2024. Clover Biopharmaceuticals, Ltd. (Clover), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced positive preliminary immunogenicity and safety data in the older adult & elderly cohort from its Phase Ⅰ trial evaluating SCB-1019 – the company’s bivalent […]
Written by
  1. Clinical

Constructive Interim Part I Outcomes of Zolmitriptan Transdermal Microporation System for the Therapy of Acute Migraine

SAN DIEGO, March 29, 2024. PassPort Applied sciences, Inc. (PPTI), based mostly in San Diego, a clinical-stage drug and medical machine growth firm, in the present day introduced optimistic interim outcomes from the Part 1 (Half A) scientific trial of Zolmitriptan PassPort using its proprietary transdermal microporation system for the remedy of acute migraine. Zolmitriptan […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Wegovy (semaglutide) Injection 2.4 mg Cardiovascular Outcomes Data Presented at the American Heart Association Scientific Sessions and Simultaneously Published in the New England Journal of Medicine

PLAINSBORO, N.J., November 11, 2023 – Novo Nordisk today announced the full results of SELECT, its landmark phase 3 cardiovascular outcomes trial investigating the effects of once-weekly Wegovy® (semaglutide) injection 2.4 mg in adults with established cardiovascular disease (CVD) and overweight or obesity but without diabetes, at the American Heart Association (AHA) annual Scientific Sessions […]
Written by
  1. Clinical

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap

LEXINGTON, Mass.–(BUSINESS WIRE)–Aug. 8, 2024– Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the achievement of the primary endpoint in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial of 0.25% reproxalap ophthalmic solution, an investigational […]
Written by
  1. Biology

Agriculture accelerated human genome evolution to capture energy from

Over the past 12,000 years, humans in Europe have dramatically increased their ability to digest carbohydrates, expanding the number of genes they have for enzymes that break down starch from an average of eight to more than 11, according to a new study by researchers from the U.S., Italy and United Kingdom. Over the past […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.